Status:
RECRUITING
Autistic Symptomatology and Sensory Profile in Children With Prader-Willi Syndrome
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Prader-Willi Syndrome
Eligibility:
All Genders
3-16 years
Brief Summary
Prader-Willi Syndrome (PWS) is a rare neurodevelopmental disorder stemming from genetic damage in the 15q11-q13 region, leading to hypothalamic dysfunction. Individuals with PWS often exhibit social i...
Detailed Description
Prader-Willi syndrome (PWS) is a rare and complex neurodevelopmental disorder (NDD) with genetic origin linked to chromosomal damage in the 15q11-q13 region and characterised by hypothalamic dysfuncti...
Eligibility Criteria
Inclusion
- Child with genetically confirmed PWS and identification of genetic subtype;
- Child aged between 3 and 16 years;
- Hospitalisation or multidisciplinary consultation planned for the child's routine follow-up at one of the investigating centres;
- No parental/legal guardian objection.
Exclusion
- Change in psychotropic treatment (start, change in dose or discontinuation) in the past 3 months;
- Inability to provide clear information to parents/legal guardian;
- Not covered by social security.
Key Trial Info
Start Date :
April 7 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 30 2026
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT06877715
Start Date
April 7 2025
End Date
October 30 2026
Last Update
May 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children Hospital
Toulouse, France